60 Degrees Pharmaceuticals (60 Degrees Pharmaceuticals) Total Stockholders Equity : $7.20 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is 60 Degrees Pharmaceuticals Total Stockholders Equity?

60 Degrees Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $7.20 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. 60 Degrees Pharmaceuticals's Book Value per Share for the quarter that ended in Mar. 2024 was $N/A. The ratio of a company's debt over equity can be used to measure how leveraged this company is. 60 Degrees Pharmaceuticals's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.02.

60 Degrees Pharmaceuticals Total Stockholders Equity Historical Data

The historical data trend for 60 Degrees Pharmaceuticals's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

60 Degrees Pharmaceuticals Total Stockholders Equity Chart

60 Degrees Pharmaceuticals Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

-17.50

-17.58

-23.58

4.87

60 Degrees Pharmaceuticals Quarterly Data
	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial							-18.96	-22.30	6.55	4.87	7.20

60 Degrees Pharmaceuticals (NAS:SXTPW) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

60 Degrees Pharmaceuticals's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(7.2	-	9.858)	/	0
	=	N/A

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

60 Degrees Pharmaceuticals's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.009	+	0.149)	/	7.2
	=	0.02

60 Degrees Pharmaceuticals Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of 60 Degrees Pharmaceuticals's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

60 Degrees Pharmaceuticals (60 Degrees Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 60 Degrees Pharmaceuticals Inc (NAS:SXTPW) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

SXTP:USA

Address

1025 Connecticut Avenue NW, Suite 1000, Washington, D.C, WA, USA, 20036

Website

https://www.60degreespharma.com

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases through Arakoda and Celgosivir.